I mean, the prevalence is skyrocketing
Regarding safety profile, in phase 2 trials for obesity and diabetes, mazdutide was discontinued due to AE by 02% of participants and SAE experienced by up to 7% of participants with mazdutide 6 mg (Tables 2 and 3)
These insights should be interpreted with a qualified healthcare provider as one data point among many, including clinical history, current medications, and metabolic biomarkers like fasting glucose and insulin levels
At Tyde Wellness, we empower individuals through community involvement, encouraging Tyde Circle members to share insights, experiences, and support each other in their wellness journeys
StatPearls Publishing Copyright 2022, StatPearls Publishing LLC
Healing requires calming that deeper imbalance not simply soothing the external symptoms